Related Articles
Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma
Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2
Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma
Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report
Expression and immunogenicity of NY‑ESO‑1 in colorectal cancer